InvestorsHub Logo
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Monday, 01/28/2013 10:56:02 AM

Monday, January 28, 2013 10:56:02 AM

Post# of 32
1:25AM Furiex Pharmaceuticals confirms Takeda's (TKPYY) receipt of FDA approval of NESINA and fixed-dose combinations OSENI and KAZANO; Furiex is entitled to receive a $25 mln milestone payment as a result of this approval (FURX) 21.24 : Under its agreement with Takeda, Furiex is entitled to receive a $25 mln milestone payment as a result of this approval, as well as royalties on sales in the United States and potential sales-based milestones. Furiex has already been receiving royalty payments from Takeda for the sale of NESINA and LIOVEL in Japan.